Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of an inhaler showing our new design;
FIG. 2 is an elevational view of one side thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a top plan view thereof;
FIG. 5 is a bottom plan view thereof.
Referenced Cited
U.S. Patent Documents
D244057 | April 12, 1977 | Aul et al. |
3667475 | June 1972 | Venturelli et al. |
3870046 | March 1975 | Elliott |
Patent History
Patent number: D282209
Type: Grant
Filed: Dec 23, 1983
Date of Patent: Jan 14, 1986
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Robert A. Fitzsimmons (Barnard Castle)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/564,932
Type: Grant
Filed: Dec 23, 1983
Date of Patent: Jan 14, 1986
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Robert A. Fitzsimmons (Barnard Castle)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/564,932
Classifications
Current U.S. Class:
D24/62